Serum pepsinogen II as a marker of both Helicobacter pylori and acetyl salicylic acid-related gastritis

被引：0
作者：
Cavallaro, L. G.
Maini, A.
Nouvenne, A.
Morana, E.
Merli, R.
Venerito, M.
Iori, V.
Cavestro, G. M.
Rugge, M.
Malfertheiner, P.
Franze, A.
Di Mario, F.
机构：
[1] Univ Parma, Dept Clin Sci, I-43100 Parma, Italy
[2] Univ Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, D-39106 Magdeburg, Germany
[3] Univ Padua, Dept Oncol & Surg Sci, Padua, Italy
[4] Hosp Parma, Gastroenterol Unit, Parma, Italy
来源：
HELICOBACTER | 2006年 / 11卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
[31]   Percentage changes in serum pepsinogen I/II ratios are useful as an index of eradication of Helicobacter pylori [J].
Furuta, T ;
Futami, H ;
Arai, H ;
Ito, G ;
Kajimura, M ;
Hanai, H ;
Kaneko, E .
GASTROENTEROLOGY, 1996, 110 (04) :A112-A112
[32]   Interaction between Helicobacter pylori and host genetic variants regulates serum level of pepsinogen II [J].
De Re, V. ;
De Zorzi, M. ;
Caggiari, L. ;
Magris, R. ;
Di Mario, F. ;
Steffan, A. ;
Canzonieri, V. ;
Cannizzaro, R. .
HELICOBACTER, 2017, 22
[33]   Serum pepsinogen (PG)I, PGII, PGI/II and Helicobacter pylori IgG in gastric carcinoma [J].
Koo, JY ;
Park, SJ ;
Yoon, BC ;
Chang, HK .
PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, :95-97
[34]   SERUM PEPSINOGEN-I IN DUODENAL-ULCER - EFFECT OF ERADICATION OF HELICOBACTER-PYLORI AND CORRELATION WITH SERUM GASTRIN AND ANTRAL GASTRITIS [J].
CHITTAJALLU, RS ;
DORIAN, CA ;
MCCOLL, KEL .
GUT, 1990, 31 (10) :A1199-A1199
[35]   Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies [J].
Cao, Qin ;
Ran, Zhi Hua ;
Xiao, Shu Dong .
JOURNAL OF DIGESTIVE DISEASES, 2007, 8 (01) :15-22
[36]   Sucrose test and serum pepsinogens as markers of inflammation and damage in Helicobacter pylori related gastritis [J].
Altavilla, N ;
Moussa, AM ;
Seghini, P ;
Cerati, E ;
Cavallaro, IG ;
Cavestro, GM ;
Dal Bò, N ;
Pilotto, A ;
Cannizzaro, R ;
Maino, M ;
Leandro, G ;
Franzè, A ;
Di Mario, F .
GUT, 2002, 51 :A30-A30
[37]   Noninvasive evaluation of Helicobacter pylori therapy:: Role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies [J].
Al-Assi, MT ;
Miki, K ;
Walsh, JH ;
Graham, DP ;
Asaka, M ;
Graham, DY .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2367-2372
[38]   HELICOBACTER-PYLORI INFECTION AND SERUM PEPSINOGEN-A, PEPSINOGEN-C, AND GASTRIN IN GASTRITIS AND PEPTIC-ULCER - SIGNIFICANCE OF INFLAMMATION AND EFFECT OF BACTERIAL ERADICATION [J].
WAGNER, S ;
HARUMA, K ;
GLADZIWA, U ;
SOUDAH, B ;
GEBEL, M ;
BLECK, J ;
SCHMIDT, H ;
MANNS, M .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1994, 89 (08) :1211-1218
[39]   Helicobacter pylori: Prevalence, transmission, and serum pepsinogen II concentrations in children of a poor periurban community in Bangladesh [J].
Sarker, SA ;
Mahalanabis, D ;
Hildebrand, P ;
Rahaman, MM ;
Bardhan, PK ;
Fuchs, G ;
Beglinger, C ;
Gyr, K .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (05) :990-995
[40]   Relation between Helicobacter pylori and atrophic gastritis in elderly: Estimation of serum (gastrin 17 and pepsinogen-I) as novel biomarkers [J].
Gomaa, Sekina I. ;
Hassan, Azza ;
El Sawy, Mohamed M. ;
Ahmed, Eman Abd Z. ;
Metwally, Mohamed .
ALEXANDRIA JOURNAL OF MEDICINE, 2012, 48 (04) :289-294
12345